Page last updated: 2024-10-17

3-hydroxybutyric acid and Glycogen Storage Disease Type I

3-hydroxybutyric acid has been researched along with Glycogen Storage Disease Type I in 1 studies

3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.

Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsalikian, E1
Simmons, P1
Gerich, JE1
Howard, C1
Haymond, MW1

Other Studies

1 other study available for 3-hydroxybutyric acid and Glycogen Storage Disease Type I

ArticleYear
Glucose production and utilization in children with glycogen storage disease type I.
    The American journal of physiology, 1984, Volume: 247, Issue:4 Pt 1

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adolescent; Blood Glucose; Body Weight; Brain; Child; Child, P

1984